Drugs / Remazolane
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07280663 | Oct 2025 | — | Second Hospital of Shanxi Medical University | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Remazolane | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07280663 ↗ |